Ad is loading...
TRIEX
Price
$23.49
Change
+$0.08 (+0.34%)
Updated
Nov 22 closing price
VTIAX
Price
$32.70
Change
+$0.07 (+0.21%)
Updated
Nov 22 closing price
Ad is loading...

TRIEX vs VTIAX

Header iconTRIEX vs VTIAX Comparison
Open Charts TRIEX vs VTIAXBanner chart's image
Nuveen International Eq Idx Retire
Price$23.49
Change+$0.08 (+0.34%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index Admiral
Price$32.70
Change+$0.07 (+0.21%)
VolumeN/A
CapitalizationN/A
TRIEX vs VTIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TRIEX vs. VTIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRIEX is a Buy and VTIAX is a Buy.

FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 442B vs. TRIEX (26.9B). VTIAX pays higher dividends than TRIEX: VTIAX (3.26) vs TRIEX (2.67). TRIEX was incepted earlier than VTIAX: TRIEX (22 years) vs VTIAX (14 years). TRIEX is a more actively managed with annual turnover of: 5.00 vs. VTIAX (4.00). TRIEX has a lower initial minimum investment than VTIAX: TRIEX (0) vs VTIAX (3000). TRIEX (10.66) and VTIAX (10.29) have marching annual gain over last year. TRIEX return over 5 years is better than : 27.57 vs. VTIAX (17.36).
TRIEXVTIAXTRIEX / VTIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years14 years-
Gain YTD4.3235.24682%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B442B6%
Annual Yield % from dividends2.673.2682%
Returns for 1 year10.6610.29104%
Returns for 3 years3.74-3.39-110%
Returns for 5 years27.5717.36159%
Returns for 10 years40.5631.30130%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTPI0.260.01
+3.92%
Petros Pharmaceuticals
TR32.940.53
+1.64%
Tootsie Roll Industries
CDNA22.580.21
+0.94%
CareDx
ATR169.881.15
+0.68%
AptarGroup
IPSC1.24-0.02
-1.59%
Century Therapeutics